Pathogenetic Mechanisms and Cardiovascular Risk
Authors:
- Cristina BianchiCBCristina Bianchi
- Riccardo C. BonadonnaRBRiccardo C. Bonadonna
- Francesco GiorginoFrancesco Giorgino
- Simona FrontoniSimona Frontoni
- Giulio MarchesiniGMGiulio Marchesini
- Franco CavalotFCFranco Cavalot
- Gisella M. CavalloGCGisella M. Cavallo
- Frida LeonettiFLFrida Leonetti
- Stefano Del PratoSPStefano Del Prato
Open Access
- 14 November 2012
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 35 (12) , 2607-2612
Abstract
OBJECTIVE To ascertain to which extent the use of HbA1c and oral glucose tolerance test (OGTT) for diagnosis of glucose tolerance could identify individuals with different pathogenetic mechanisms and cardiovascular risk profile. RESEARCH DESIGN AND METHODS A total of 844 subjects (44% men; age 49.5 ± 11 years; BMI 29 ± 5 kg/m2) participated in this study. Parameters of β-cell function were derived from deconvolution of the plasma C-peptide concentration after a 75-g OGTT and insulin sensitivity assessed by homeostasis model assessment of insulin resistance (IR). Cardiovascular risk profile was based on determination of plasma lipids and measurements of body weight, waist circumference, and blood pressure. Glucose regulation categories by OGTT and HbA1c were compared with respect to insulin action, insulin secretion, and cardiovascular risk profile. RESULTS OGTT results showed 42% of the subjects had prediabetes and 15% had type 2 diabetes mellitus (T2DM), whereas the corresponding figures based on HbA1c were 38 and 11%, with a respective concordance rate of 54 and 44%. Subjects meeting both diagnostic criteria for prediabetes presented greater IR and impairment of insulin secretion and had a worse cardiovascular risk profile than those with normal glucose tolerance at both diagnostic methods. In a logistic regression analyses adjusted for age, sex, and BMI, prediabetic subjects, and even more T2DM subjects by OGTT, had greater chance to have IR and impaired insulin secretion. CONCLUSIONS HbA1c identifies a smaller proportion of prediabetic individuals and even a smaller proportion of T2DM individuals than OGTT, with no difference in IR, insulin secretion, and cardiovascular risk profile. Subjects fulfilling both diagnostic methods for prediabetes or T2DM are characterized by a worse metabolic profile.Keywords
This publication has 28 references indexed in Scilit:
- Moving to an A1C-Based Diagnosis of Diabetes Has a Different Impact on Prevalence in Different Ethnic GroupsDiabetes Care, 2009
- Performance of an A1C and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, ChinaDiabetes Care, 2009
- A1C Cut Points to Define Various Glucose Intolerance Groups in Asian IndiansDiabetes Care, 2009
- Performance Characteristics of the New Definition of DiabetesDiabetes Care, 2009
- A1C and Diabetes Diagnosis: The Rancho Bernardo StudyDiabetes Care, 2009
- Relationship Between A1C and Glucose Levels in the General Dutch PopulationDiabetes Care, 2009
- Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. AdultsDiabetes Care, 2009
- The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose toleranceAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Loss of beta cell function as fasting glucose increases in the non-diabetic rangeDiabetologia, 2004
- Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) studyDiabetologia, 2003